Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · IEX Real-Time Price · USD
0.308
-0.029 (-8.63%)
At close: Jul 19, 2024, 4:00 PM
0.310
+0.002 (0.65%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Sonoma Pharmaceuticals Stock Forecast
SNOA's stock price has decreased by -73.52% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SNOA stock has a target of 3.25, which predicts an increase of 955.19% from the current stock price of 0.31.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 5, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for SNOA is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $3.25 | Strong Buy | Initiates | $3.25 | +955.19% | Sep 5, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 6, 2018 |
| Maxim Group | Maxim Group | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 10, 2017 |
Financial Forecast
Revenue This Year
18.27M
from 12.74M
Increased by 43.45%
Revenue Next Year
22.54M
from 18.27M
Increased by 23.40%
EPS This Year
-0.46
from -0.53
EPS Next Year
-0.13
from -0.46
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 18.8M | 23.2M |
| Avg | 18.3M | 22.5M |
| Low | 17.6M | 21.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 47.7% | 27.0% |
| Avg | 43.4% | 23.4% |
| Low | 37.8% | 18.6% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.47 | -0.14 |
| Avg | -0.46 | -0.13 |
| Low | -0.44 | -0.13 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.